000			01940 a2200625 4500
005			20250516150232.0
264		0	_c20140218
008			201402s 0 0 eng d
022			_a1532-3080
024	7		_a10.1016/j.breast.2013.03.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aTorrisi, R
245	0	0	_aPotential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience. _h[electronic resource]
260			_bBreast (Edinburgh, Scotland) _cAug 2013
300			_a419-24 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant _xmethods
650	0	4	_aCohort Studies
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKi-67 Antigen _xmetabolism
650	0	4	_aLogistic Models
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aReceptors, Progesterone _xmetabolism
650	0	4	_aTreatment Outcome
700	1		_aGarcia-Etienne, C A
700	1		_aLosurdo, A
700	1		_aMorenghi, E
700	1		_aDi Tommaso, L
700	1		_aGatzemeier, W
700	1		_aSagona, A
700	1		_aFernandes, B
700	1		_aRossetti, C
700	1		_aEboli, M
700	1		_aRubino, A
700	1		_aBarbieri, E
700	1		_aAndreoli, C
700	1		_aOrefice, S
700	1		_aGandini, C
700	1		_aRota, S
700	1		_aZuradelli, M
700	1		_aMasci, G
700	1		_aSantoro, A
700	1		_aTinterri, C
773	0		_tBreast (Edinburgh, Scotland) _gvol. 22 _gno. 4 _gp. 419-24
856	4	0	_uhttps://doi.org/10.1016/j.breast.2013.03.013 _zAvailable from publisher's website
999			_c22724045 _d22724045